{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:35:02Z","timestamp":1794479702070,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.isci.2026.117762","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:48:25Z","timestamp":1791830905000},"page":"117762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The immunophenotypic landscape of newly diagnosed acute myeloid leukemia: Associations with genotype and outcomes"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-4131","authenticated-orcid":false,"given":"Tim R.","family":"Mocking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1346-6606","authenticated-orcid":false,"given":"Tom","family":"Reuvekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2179-4870","authenticated-orcid":false,"given":"Lukas H.","family":"Haaksma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6249-6262","authenticated-orcid":false,"given":"Eirini","family":"Papavasileiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Kelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemijn J.","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri A.","family":"Breems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9358-9704","authenticated-orcid":false,"given":"Bj\u00f8rn T.","family":"Gjertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimonas","family":"Gri\u0161kevi\u010dius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Juliusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan A.","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4676-7931","authenticated-orcid":false,"given":"Markus G.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-3351","authenticated-orcid":false,"given":"Jakob R.","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Porkka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.W.M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Gradowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"L\u00f6wenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert J.","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan A.","family":"van de Loosdrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-8467","authenticated-orcid":false,"given":"David C.","family":"de Leeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Cloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.M.","family":"Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-6193","authenticated-orcid":false,"given":"Costa","family":"Bachas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117762_bib1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","year":"2013","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.isci.2026.117762_bib2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.2022016033","article-title":"Proteomic and phosphoproteomic landscapes of acute myeloid leukemia","volume":"140","author":"Kramer","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117762_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117762_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1158\/2643-3230.BCD-24-0256","article-title":"Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN study","volume":"6","author":"Lachowiez","year":"2025","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.isci.2026.117762_bib5","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1182\/bloodadvances.2024015734","article-title":"Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine","volume":"9","author":"Zhao","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.117762_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41408-022-00712-7","article-title":"Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia","volume":"12","author":"Vergez","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.isci.2026.117762_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cyto.b.22230","article-title":"Unraveling genotype\u2013phenotype associations and predictive modeling of outcome in acute myeloid leukemia","volume":"108","author":"Couckuyt","year":"2025","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.isci.2026.117762_bib8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.2023021680","article-title":"CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia","volume":"144","author":"Mazziotta","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117762_bib9","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S2152-2650(20)30466-3","article-title":"Targeting CD123 in AML","volume":"20","author":"Lane","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.isci.2026.117762_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12885-021-09116-5","article-title":"Targeting CD33 for acute myeloid leukemia therapy","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.117762_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymthe.2018.10.001","article-title":"CD7 CAR T cells for the therapy of acute myeloid leukemia","volume":"27","author":"Gomes-Silva","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.117762_bib12","article-title":"Anti-CD19 CAR-T cell therapy in relapsed\/refractory t (8; 21) acute myeloid leukemia with aberrant CD19 expression","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117762_bib13","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/j.bbmt.2016.12.413","article-title":"Targeting CLEC12A with chimeric antigen receptor T cells can overcome the chemotherapy refractoriness of leukemia stem cells","volume":"23","author":"Kenderian","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.isci.2026.117762_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70155","article-title":"Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy","volume":"9","author":"van der Schans","year":"2025","journal-title":"HemaSphere"},{"key":"10.1016\/j.isci.2026.117762_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/ijlh.14348","article-title":"Immunophenotypic features of early haematopoietic and leukaemia stem cells","volume":"46","author":"Reuvekamp","year":"2024","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.isci.2026.117762_bib16","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1182\/blood.V80.12.3182.3182","article-title":"Distinctive immunophenotypic features of t (8; 21)(q22; q22) acute myeloblastic leukemia in children","volume":"80","author":"Hurwitz","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117762_bib17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-04-1816","article-title":"Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells","volume":"11","author":"Lin","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117762_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajcp\/aqad019","article-title":"Clinicopathologic Features of IDH2 R172\u2013Mutated Myeloid Neoplasms","volume":"160","author":"Davis","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.isci.2026.117762_bib19","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117762_bib20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.2025031480","article-title":"2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party","volume":"147","author":"Cloos","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.117762_bib21","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1002\/cpcy.66","article-title":"Immunophenotypic detection of measurable residual (stem cell) disease using LAIP approach in acute myeloid leukemia","volume":"91","author":"Zeijlemaker","year":"2019","journal-title":"Curr. Protoc. Cytom."},{"key":"10.1016\/j.isci.2026.117762_bib22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry. A."},{"key":"10.1016\/j.isci.2026.117762_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117762_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12859-025-06285-z","article-title":"Computationally efficient multi-sample flow cytometry data analysis using Gaussian mixture models","volume":"26","author":"Rutten","year":"2025","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2026.117762_bib25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cyto.a.23030","article-title":"Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data","volume":"89","author":"Weber","year":"2016","journal-title":"Cytometry A"},{"key":"10.1016\/j.isci.2026.117762_bib26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.12688\/f1000research.11622.1","article-title":"CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets","volume":"6","author":"Nowicka","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.isci.2026.117762_bib27","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117762_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ajh.25018","article-title":"A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1\/2 mutations and improved outcome","volume":"93","author":"Mason","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2026.117762_bib29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.leu.2402865","article-title":"HLA-DR antigen-negative acute myeloid leukemia","volume":"17","author":"Wetzler","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.117762_bib30","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1080\/10428194.2021.1885659","article-title":"Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome","volume":"62","author":"Roerden","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.isci.2026.117762_bib31","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1016\/j.clml.2025.08.013","article-title":"Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR","volume":"25","author":"R\u00f6hnert","year":"2025","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.isci.2026.117762_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s43856-024-00700-x","article-title":"Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models","volume":"4","author":"Mocking","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.isci.2026.117762_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-025-02747-8","article-title":"Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial: MINIMAL RESIDUAL DISEASE","volume":"39","author":"Mocking","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.117762_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70138","article-title":"Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia","volume":"9","author":"Mocking","year":"2025","journal-title":"HemaSphere"},{"key":"10.1016\/j.isci.2026.117762_bib35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/bloodadvances.2020003855","article-title":"Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial","volume":"5","author":"L\u00f6wenberg","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.117762_bib36","article-title":"Comprehensive protocol to sample and process bone marrow for measuring measurable residual disease and leukemic stem cells in acute myeloid leukemia","volume":"133","author":"Cloos","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.isci.2026.117762_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cyto.a.24501","article-title":"PeacoQC: peak-based selection of high quality cytometry data","volume":"101","author":"Emmaneel","year":"2022","journal-title":"Cytometry. A."},{"key":"10.1016\/j.isci.2026.117762_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2105-10-106","article-title":"flowCore: a Bioconductor package for high throughput flow cytometry","volume":"10","author":"Hahne","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2026.117762_bib39","article-title":"flowStats: Statistical methods for the analysis of flow cytometry data","volume":"3","author":"Hahne","year":"2009","journal-title":"R Packag version"},{"key":"10.1016\/j.isci.2026.117762_bib40","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1200\/JCO.2012.45.9628","article-title":"High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON\/SAKK AML 42A study","volume":"31","author":"Terwijn","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117762_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41375-024-02137-6","article-title":"Mapping AML heterogeneity-multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses","volume":"38","author":"Severens","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2026.117762_bib42","first-page":"1","article-title":"The igraph software","volume":"1695","author":"Csardi","year":"2006","journal-title":"Complex Syst."},{"key":"10.1016\/j.isci.2026.117762_bib43","first-page":"874","article-title":"Package \u2018glmnet\u2019","volume":"595","author":"Friedman","year":"2021","journal-title":"CRAN R Repositary"},{"key":"10.1016\/j.isci.2026.117762_bib44","first-page":"2014","article-title":"A package for survival analysis in R","volume":"2","author":"Therneau","year":"2015","journal-title":"R package version"},{"key":"10.1016\/j.isci.2026.117762_bib45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226031433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:14:05Z","timestamp":1794478445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226031433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589004226031433"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117762","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunophenotypic landscape of newly diagnosed acute myeloid leukemia: Associations with genotype and outcomes","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117762"}}